Member Log-in

I forgot my password

Not a Member? Register

Donor Transitions From HIV Programs: What Is The Impact On Vulnerable Populations?

“Many middle-income countries are transitioning away from donor-funded health programs in a range of areas including immunization, maternal and child health, tuberculosis, malaria, and HIV. Unless these donor exits are managed well, they could imperil the sustainability of the remarkable gains that have been achieved over the past two decades in fighting killer infectious diseases and maternal and child health conditions.

Donor exits could particularly jeopardize gains in global HIV control. Countries and donors have spent more than $500 billion on HIV programs in low- and middle-income countries over the past two decades, but the gains from these investments are fragile. When donor funding for HIV programs ends, there is an especially acute risk of HIV re-emerging among “key populations”: vulnerable minority groups such as sex workers, men who have sex with men, people who inject drugs, transgender populations, and prisoners.

Too little attention has been paid to date to the needs of key populations during transition. This is a mistake. Unless departing donors and “graduating” countries address the risks that key populations face, these populations could suffer serious health setbacks, and the larger national achievements in fighting HIV/AIDS could easily be undermined or even reversed.”

Read the full, original post for the full perspective on the impact of transitioning on vulnerable populations.

You May Also Like

Update for Countries and Regional Partners Requesting Gavi Post-transition Support

In November 2017, the Gavi Board approved continued Gavi Alliance engagement with transitioned countries and a budget allocation of up to US$30m to support these countries until 2020. Support is being provided for technical assistance in key programmatic areas, including supply chain, LMC and data, paying special attention to innovative approaches and government commitment to … Continued

Continuing Pneumococcal Vaccination After Gavi Transition in Kenya at Full Price is Cost-effective and Could Save Thousands of Lives

This news release was originally published on EurekAlert. Below is an excerpt from the news release. Co-led by the London School of Hygiene & Tropical Medicine and the KEMRI-Wellcome Trust Research Program, the Pneumococcal Conjugate Vaccine Impact Study estimated that continuing the vaccine beyond 2022 would prevent – in the first ten years – more than … Continued

Transition to Program Budgeting in Health: Experience from Countries and Lessons Learned

WHO’s Department of Health Systems Governance and Financing is providing support to Ministries of Health in this transition process, with the following aims: 1) building the knowledge base on good practices in health budget reforms, including the development of an online health budget portal and country case studies; 2) providing technical support and guidance to … Continued

Choose a Language